Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea

Francisco Campos-Rodriguez, Monica Gonzalez-Martinez, Angeles Sanchez-Armengol, Bernabe Jurado-Gamez, Jose Cordero-Guevara, Nuria Reyes-Nuñez, Maria F Troncoso, Araceli Abad-Fernandez, Joaquin Teran-Santos, Julian Caballero-Rodriguez, Mercedes Martin-Romero, Ana Encabo-Motiño, Lirios Sacristan-Bou, Javier Navarro-Esteva, Maria Somoza-Gonzalez, Juan F Masa, Maria A Sanchez-Quiroga, Beatriz Jara-Chinarro, Belen Orosa-Bertol, Miguel A Martinez-Garcia, Spanish Sleep Network, Francisco Campos-Rodriguez, Monica Gonzalez-Martinez, Angeles Sanchez-Armengol, Bernabe Jurado-Gamez, Jose Cordero-Guevara, Nuria Reyes-Nuñez, Maria F Troncoso, Araceli Abad-Fernandez, Joaquin Teran-Santos, Julian Caballero-Rodriguez, Mercedes Martin-Romero, Ana Encabo-Motiño, Lirios Sacristan-Bou, Javier Navarro-Esteva, Maria Somoza-Gonzalez, Juan F Masa, Maria A Sanchez-Quiroga, Beatriz Jara-Chinarro, Belen Orosa-Bertol, Miguel A Martinez-Garcia, Spanish Sleep Network

Abstract

Continuous positive airway pressure (CPAP) reduces blood pressure levels in hypertensive patients with obstructive sleep apnoea (OSA). However, the role of CPAP in blood pressure and the metabolic profile in women has not yet been assessed. In this study we investigated the effect of CPAP on blood pressure levels and the glucose and lipid profile in women with moderate-to-severe OSA.A multicentre, open-label, randomised controlled trial was conducted in 307 women diagnosed with moderate-to-severe OSA (apnoea-hypopnoea index ≥15 events·h-1) in 19 Spanish Sleep Units. Women were randomised to CPAP (n=151) or conservative treatment (n=156) for 12 weeks. Changes in office blood pressure measures as well as in the glucose and lipid profile were assessed in both groups.Compared with the control group, the CPAP group achieved a significantly greater decrease in diastolic blood pressure (-2.04 mmHg, 95% CI -4.02- -0.05; p=0.045), and a nonsignificantly greater decrease in systolic blood pressure (-1.54 mmHg, 95% CI -4.58-1.51; p=0.32) and mean blood pressure (-1.90 mmHg, 95% CI -4.0-0.31; p=0.084). CPAP therapy did not change any of the metabolic variables assessed.In women with moderate-to-severe OSA, 12 weeks of CPAP therapy improved blood pressure, especially diastolic blood pressure, but did not change the metabolic profile, compared with conservative treatment.

Trial registration: ClinicalTrials.gov NCT02047071.

Conflict of interest statement

Conflict of interest: None declared.

Copyright ©ERS 2017.

References

    1. Eur Respir J. 2012 Aug;40(2):386-93
    1. J Clin Sleep Med. 2014 Dec 15;10(12):1295-302
    1. Am J Respir Crit Care Med. 2016 Aug 15;194(4):486-92
    1. Am J Respir Crit Care Med. 2016 Aug 15;194(4):476-85
    1. Eur Respir J. 2011 May;37(5):1137-43
    1. Respir Med. 2004 Oct;98(10):984-9
    1. Arch Bronconeumol. 2011 Mar;47(3):143-56
    1. Sleep Breath. 2015 Sep;19(3):809-17
    1. Chest. 2013 Sep;144(3):915-922
    1. Hypertension. 2007 Aug;50(2):417-23
    1. Sleep. 2004 Mar 15;27(2):305-11
    1. Am J Respir Crit Care Med. 2010 Apr 1;181(7):718-26
    1. Eur Respir J. 2006 Jun;27(6):1229-35
    1. Am J Respir Crit Care Med. 2016 Nov 15;194(10 ):1286-1294
    1. Sleep Breath. 2005 Dec;9(4):176-80
    1. J Appl Physiol (1985). 2001 Nov;91(5):2248-54
    1. Arch Intern Med. 2007 Apr 23;167(8):757-64
    1. J Clin Sleep Med. 2012 Oct 15;8(5):587-96
    1. Am J Epidemiol. 2013 May 1;177(9):1006-14
    1. Sleep. 2004 Sep 15;27(6):1113-20
    1. Eur Respir J. 2013 Mar;41(3):523-38
    1. Am J Respir Crit Care Med. 2000 May;161(5):1465-72
    1. J Hypertens. 2013 Jul;31(7):1281-357
    1. Eur Respir J. 2013 Mar;41(3):610-5
    1. Am J Respir Crit Care Med. 2015 Jul 1;192(1):96-105
    1. Am J Respir Crit Care Med. 2004 Dec 1;170(11):1218-24
    1. Arch Intern Med. 1996 Nov 25;156(21):2445-51
    1. Sleep. 2005 Mar;28(3):309-14
    1. Hypertension. 2000 Nov;36(5):801-7
    1. Chest. 2014 Apr;145(4):762-771
    1. Eur Respir J. 2014 Aug;44(2):405-14
    1. JAMA. 2003 May 21;289(19):2560-72
    1. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):722-6
    1. Lancet. 2014 Aug 16;384(9943):591-598
    1. N Engl J Med. 2014 Jun 12;370(24):2265-75
    1. Circulation. 2015 Oct 6;132(14 ):1329-37
    1. Chest. 2016 Jan;149(1):288-90
    1. J Clin Hypertens (Greenwich). 2015 Mar;17(3):215-22
    1. JAMA. 2013 Dec 11;310(22):2407-15

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner